Skip to main content
PMC home page
Gut logoLink to Gut
. 1970 Jul;11(7):559–566. doi: 10.1136/gut.11.7.559

A controlled trial of glycopyrronium and l-hyoscyamine in the long-term treatment of duodenal ulcer

Michael D Kaye, J Rhodes, Peter Beck, Peter M Sweetnam, G T Davies, K T Evans
PMCID: PMC1553068  PMID: 4916211

Abstract

A controlled single-blind trial has been carried out to determine the value of long-term anticholinergic therapy in duodenal ulcer. Of 106 male patients with symptomatic and radiologically proven duodenal ulcer admitted to the trial, 91 completed the study. Patients were divided randomly into three groups. They received either glycopyrronium, or 1-hyoscyamine in a sustained-release form, or inert tablets for one year.

Progress was judged on the basis of frequency and severity of symptoms, monthly assessments by patients, antacid consumption, and radiology. By all criteria, glycopyrronium and 1-hyoscyamine were not significantly superior to placebo.

Symptomatic improvement, both subjective and objective, occurred in approximately 80% of all patients during the year of observation; there was no significant difference between the groups.

Full text

PDF
559

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABBOTT W. E., SOURIAL A. S., KRIEGER H., LEVEY S. Effect of glycopyrrolate (Robanul) on basal and histamine- or insulin-induced gastric secretion. Ann N Y Acad Sci. 1962 Feb 28;99:163–173. doi: 10.1111/j.1749-6632.1962.tb45300.x. [DOI] [PubMed] [Google Scholar]
  2. BARMAN M. L., LARSON R. K. THE EFFECT OF GLYCOPYRROLATE ON NOCTURNAL GASTRIC SECRETION IN PEPTIC ULCER PATIENTS. Am J Med Sci. 1963 Sep;246:325–328. doi: 10.1097/00000441-196309000-00011. [DOI] [PubMed] [Google Scholar]
  3. Christiansen P. M., Rodbro P. Gastric secretory patterns before and during treatment with 1-hyoscyamine. Scand J Gastroenterol. 1967;2(4):251–256. doi: 10.3109/00365526709180077. [DOI] [PubMed] [Google Scholar]
  4. DOTEVALL G., SCHROEDER G., WALAN A. THE EFFECT OF POLDINE, GLYCOPYRROLATE AND 1-HYOSCYAMINE ON GASTRIC SECRETION OF ACID IN MAN. Acta Med Scand. 1965 Feb;177:169–174. doi: 10.1111/j.0954-6820.1965.tb01819.x. [DOI] [PubMed] [Google Scholar]
  5. Kaye M. D., Beck P., Rhodes J., Sweetnam P. M. Gastric acid secretion in patients with duodenal ulcer treated for one year with anticholinergic drugs. Gut. 1969 Oct;10(10):774–778. doi: 10.1136/gut.10.10.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kaye M. D., Rhodes J., Sweetnam P. M. Clinical evaluation of three long-acting anticholinergic compounds. Gut. 1968 Oct;9(5):590–596. doi: 10.1136/gut.9.5.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LENNARD-JONES J. E. Experimental and clinical observations of poldine in treatment of duodenal ulcer. Br Med J. 1961 Apr 15;1(5232):1071–1076. doi: 10.1136/bmj.1.5232.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MELROSE A. G., PINKERTON I. W. Clinical evaluation of poldine methosulphate. Br Med J. 1961 Apr 15;1(5232):1076–1078. doi: 10.1136/bmj.1.5232.1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MOELLER H. C. Physiological effects and clinical evaluation of glycopyrrolate in peptic ulcer disease. Ann N Y Acad Sci. 1962 Feb 28;99:158–162. doi: 10.1111/j.1749-6632.1962.tb45299.x. [DOI] [PubMed] [Google Scholar]
  10. POSEY E. L., Jr Management of peptic ulcer with glycopyrrolate. Am J Dig Dis. 1962 Oct;7:863–872. doi: 10.1007/BF02231863. [DOI] [PubMed] [Google Scholar]
  11. RUFFIN J. M., CAYER D. The role of anticholinergic drugs in treatment of peptic ulcer disease. Ann N Y Acad Sci. 1962 Feb 28;9:179–182. doi: 10.1111/j.1749-6632.1962.tb45302.x. [DOI] [PubMed] [Google Scholar]
  12. SUN D. C. Comparative study on the effect of glycopyrrolate and propantheline on basal gastric secretion. Ann N Y Acad Sci. 1962 Feb 28;99:153–157. doi: 10.1111/j.1749-6632.1962.tb45298.x. [DOI] [PubMed] [Google Scholar]
  13. SUN D. C. LONG-TERM ANTICHOLINERGIC THERAPY FOR PREVENTION OF RECURRENCES IN DUODENAL ULCER. Am J Dig Dis. 1964 Oct;9:706–716. doi: 10.1007/BF02237730. [DOI] [PubMed] [Google Scholar]
  14. SUN D. C. The medical management of duodenal ulcer and long term study with drug therapy in the prevention of recurrences. Ann N Y Acad Sci. 1962 Feb 28;99:104–113. doi: 10.1111/j.1749-6632.1962.tb45293.x. [DOI] [PubMed] [Google Scholar]
  15. Trevino H., Anderson J., Davey P. G., Henley K. S. The effect of glycopyrrolate on the course of symptomatic duodenal ulcer. Am J Dig Dis. 1967 Oct;12(10):983–987. doi: 10.1007/BF02233256. [DOI] [PubMed] [Google Scholar]
  16. WATKINSON G. The incidence of chronic peptic ulcer found at necropsy: a study of 20,000 examinations performed in Leeds in 1930-49 and in England and Scotland in 1956. Gut. 1960 Mar;1:14–30. doi: 10.1136/gut.1.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES